The FDA has cleared Abbott Laboratories' Simcor, a combination of simvastatin and its Niaspan, developed to boost "good" cholesterol and reduce "bad" cholesterol and triglyceride levels.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||